The Plasma Resectoscope market is estimated to be valued at US$ 303.5 Mn in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Plasma resectoscope is a medical device used in endoscopic surgeries. It is used to resect or cut tissues and blood vessels using high-frequency electrical current. Plasma resectoscopes are commonly used in surgeries related to prostate conditions such as benign prostatic hyperplasia (BPH) and prostate cancer. The resectoscope is introduced through the urethra into the prostate gland and uses a combination of electric current and saline solution to cut and remove prostate tissue for relieve symptoms and diagnostic purposes.

Market Dynamics:
Growing prevalence of prostate conditions primarily drives the growth of the plasma resectoscope market. According to the American Cancer Society, prostate cancer is the second most common cancer among men in the United States and one in eight men will be diagnosed with prostate cancer in their lifetime. In addition, BPH affects nearly 50% of men aged 50 years and up to 90% aged above 80 years. Thus, rising geriatric population is leading to increasing incidences of prostate conditions boosting the demand for plasma resectoscopes. Furthermore, technological advancements integrating advanced features such as irrigation, triangulation light systems, and HD cameras to plasma resectoscopes also support the market growth.

Read More - https://justpaste.me/51x5